Skip to main content

Table 2 Virologic, Biochemical Variables of Patients at 24 Weeks' Treatment

From: Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial

Variable

CIFN group (n = 71)

IFN-alpha group (n = 68)

ALT normalization, n (%)

38 (53.5)

41 (60.3)

Loss of HBV-DNA, n (%)

18 (25.4)

14 (20.6)

HBeAg/anti-HBe seroconversion, n (%)

10 (14.1)

15 (22.1)

Loss of HbeAg, n (%)

10 (14.1)

7 (10.3)

Complete response, n (%)

5 (7.0)

5 (7.4)

Partial response, n (%)

25 (35.2)

23 (33.8)

  1. CIFN, consensus interferon; IFN, interferon